Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.74M
Expense Ratio	0.85%
PE Ratio	42.02
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.57%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	n/a
Payout Ratio	24.37%

Volume	3,532
Open	39.57
Previous Close	39.43
Day's Range	39.53 - 39.84
52-Week Low	31.08
52-Week High	42.41
Beta	1.09
Holdings	35
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

54.77% of assets

Name	Symbol	Weight
Kratos Defense & Security Solutions, Inc.	KTOS	6.21%
Legence Corp.	LGN	6.04%
MYR Group Inc.	MYRG	5.97%
MasTec, Inc.	MTZ	5.93%
Madrigal Pharmaceuticals, Inc.	MDGL	5.45%
Super Micro Computer, Inc.	SMCI	5.23%
AppLovin Corporation	APP	5.04%
Alphabet Inc.	GOOGL	4.98%
Guidewire Software, Inc.	GWRE	4.97%
Privia Health Group, Inc.	PRVA	4.94%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 8.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.20%.